about
Nonredundant function of soluble LTα3 produced by innate lymphoid cells in intestinal homeostasis.Commensal microbiota influence systemic autoimmune responses.Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis.Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infectionNovel mouse model to study T cell-dependent IgA induction in vivo.Cellular source and molecular form of TNF specify its distinct functions in organization of secondary lymphoid organs.Inflammation-induced formation of fat-associated lymphoid clustersLymphotoxin controls the IL-22 protection pathway in gut innate lymphoid cells during mucosal pathogen challenge.Tumor necrosis factor, lymphotoxin and cancer.Cellular sources of pathogenic and protective TNF and experimental strategies based on utilization of TNF humanized mice.Modern anti-cytokine therapy of autoimmune diseases.Making anti-cytokine therapy more selective: Studies in mice.Microbiota, intestinal immunity, and mouse bustle.Can we design a better anti-cytokine therapy?ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock.Transglutaminase-catalyzed covalent multimerization of Camelidae anti-human TNF single domain antibodies improves neutralizing activity.Distinct biological activity of lipopolysaccharides with different lipid A acylation status from mutant strains of Yersinia pestis and some members of genus Psychrobacter.Experimental models of arthritis in which pathogenesis is dependent on TNF expression.VHH-Based Bispecific Antibodies Targeting Cytokine ProductionExperimental applications of TNF-reporter mice with far-red fluorescent label.Pathogenic and protective functions of TNF in neuroinflammation are defined by its expression in T lymphocytes and myeloid cells.Modalities of experimental TNF blockade in vivo: mouse models.Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a reviewEomes controls the development of Th17-derived (non-classic) Th1 cells during chronic inflammationIntrinsic TNFR2 signaling in T regulatory cells provides protection in CNS autoimmunityNovel tumor necrosis factor-knockout mice that lack Peyer's patches[Chromosomal localization and molecular organization of human genomic fragment containing TNF/LT locus in transgenic mice]Comment on "experimental arthritis triggers periodontal disease in mice: involvement of TNF-α and the oral microbiota"Accelerated thymic atrophy as a result of elevated homeostatic expression of the genes encoded by the TNF/lymphotoxin cytokine locusModulation of bioavailability of proinflammatory cytokines produced by myeloid cellsc-Maf-dependent Treg cell control of intestinal TH17 cells and IgA establishes host-microbiota homeostasisSingle-cell transcriptomes of murine bone marrow stromal cells reveal niche-associated heterogeneityCytokines as Mediators of Neuroinflammation in Experimental Autoimmune Encephalomyelitis
P50
Q35060073-B79D2D99-C0D3-46C7-A7E8-010747B9DDE1Q35090666-D31C2884-F11C-4E17-9344-B0FC38F994A2Q35152324-788332B2-B28E-4B82-9742-79EA7F602320Q35489105-8BAF8582-03EA-4813-8F91-1C24CED486BDQ35581675-F144A8D1-CDAF-49A1-857E-DAE1D4B6EA70Q35876885-08336441-FF4F-4E14-9C14-CC1FBAD8A318Q35882546-6FEE651C-A47B-4E83-A3A6-9277681D19A9Q36031510-385F1A23-4C36-44DF-8FBA-73A2F8B5E371Q37692372-E7D3151C-625C-48AC-A04B-329D7A341304Q38177024-308B85A1-E8D1-4FC9-9A13-8253E2DC0010Q38365336-DCDA8DE2-4F60-4F9F-96CD-A4001A775EAFQ38953719-9CCA65CD-1BF1-40FD-9042-04B0D3368C38Q38962606-4057FB30-AB4A-461D-AF6F-F00253F51715Q39331398-21B93CDE-20F9-4F25-AEB6-6FA4BC1C6ED4Q39707454-C37C7472-8FCF-4939-AECD-C6176697CC7EQ39852075-D93FED0E-14CD-4033-9066-0CC0B644FAEBQ41378401-B49FAC0E-B28A-4F95-8D6E-B23C1819F77EQ41463596-C5146351-CF80-4199-BC9A-F6FFA7AA7469Q41619629-EE025648-21BB-4DB6-8577-6F02FC5B3A61Q50456936-D9908E5F-A24A-4288-B6AE-0C735F2D7F71Q52891946-06E4043F-5ACF-429A-AD7D-5D3151920138Q52899889-CE09020B-5C21-4448-8383-175CF2D7425CQ57470182-02222756-9A79-431A-BBDC-0D63D438BEB4Q59386613-544DF5F4-D716-4D6B-909B-A662A996946EQ60310882-357F5840-35ED-4BCC-BC40-49BDA82DF8F1Q81653276-FF4C9CE3-FC11-4792-9337-1A76757D1489Q82300253-01C662DC-4360-47DE-A3D6-67EBC2AA5082Q83082778-ABD8606C-ED06-4C1B-8CF7-C1E71D04E13CQ84522851-E7C5095F-097A-4F37-AD93-CC8CA579996BQ91519653-67B5E57C-8F87-4CCD-8194-ACBD35E0BEE8Q91692053-A0EE3AE9-88DC-4166-B661-5AB86633E568Q92435546-6AA59FBC-98FB-469C-AB18-CCCD2C356C10Q93349152-B9053D7C-9467-44B0-A7A5-9C8290204F24
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0002-4597-2087
@en
name
Andrei Alexejewitsch Kruglow
@de
Andrey A Kruglov
@ast
Andrey A Kruglov
@nl
Andrey Kruglov
@en
Андрей Алексеевич Круглов
@ru
type
label
Andrei Alexejewitsch Kruglow
@de
Andrey A Kruglov
@ast
Andrey A Kruglov
@nl
Andrey Kruglov
@en
Андрей Алексеевич Круглов
@ru
altLabel
Andrei Kruglow
@de
Andrey A Kruglov
@en
prefLabel
Andrei Alexejewitsch Kruglow
@de
Andrey A Kruglov
@ast
Andrey A Kruglov
@nl
Andrey Kruglov
@en
Андрей Алексеевич Круглов
@ru
P106
P21
P31
P496
0000-0002-4597-2087